Melanoma staging: facts and controversies.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Dermatology

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clindermatol.2009.06.012PMID 20541679
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultrasound Examination of Regional Lymph Nodes

  2010cited by this paper
• PET CT imaging in patients undergoing sentinel node biopsy for melanoma

  2009cited by this paper
• High-Risk Melanoma: Accuracy of FDG PET/CT with Added CT Morphologic Information for Detection of Metastases

  2009cited by this paper
• Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit

  2008cited by this paper
• Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma

  2008cited by this paper
• Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B

  2007cited by this paper
• High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

  2007cited by this paper
• PET CT imaging in patients undergoing sentinel node biopsy for melanoma.

  2007cited by this paper
• Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.

  2006cited by this paper
• Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy

  2006cited by this paper
• Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.

  2006cited by this paper
• Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.

  2006cited by this paper
• Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients

  2006cited by this paper
• Cutaneous melanoma.

  2005cited by this paper
• Inefficacy of F‐18 fluorodeoxy‐D‐glucose‐positron emission tomography scans for initial evaluation in early‐stage cutaneous melanoma

  2005cited by this paper
• Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis.

  2004cited by this paper
• Prognostic Value of Serum S-100B in Malignant Melanoma

  2004cited by this paper
• Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II

  2004cited by this paper
• Role of surgery in patients with stage IV melanoma

  2004cited by this paper
• Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?

  2004cited by this paper
• Recommendations for an effective follow-up strategy in melanoma patients should be tailored to the investigations performed during initial staging.

  2003cited by this paper
• Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.

  2003cited by this paper
• Surveillance and Follow-up Examinations in Cutaneous Melanoma

  2003cited by this paper
• UK guidelines for the management of cutaneous melanoma.

  2002cited by this paper
• Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data

  2002cited by this paper
• UK guidelines for the management of cutaneous melanoma

  2002cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Regional Nodal Surgery for Melanoma Impacts Recurrence Rates and Survival

  2000cited by this paper
• Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow‐up of patients with cutaneous melanoma

  2000cited by this paper
• Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

  1999cited by this paper
• Primary staging and follow‐up of high risk melanoma patients with whole‐body 18F‐fluorodeoxyglucose positron emission tomography

  1998cited by this paper
• Surgery for metastatic melanoma.

  1998cited by this paper
• Use of chest radiography in the initial evaluation of patients with localized melanoma.

  1998cited by this paper
• Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma.

  1997cited by this paper
• Prolonged survival of 2 years or longer for patients with disseminated melanoma

  1997cited by this paper
• [Tumor follow-up using sonography and computed tomography in the abdominal region of patients with malignant melanoma].

  1992cited by this paper

• Diagnostic accuracy of imaging studies for initial staging of T2b-T4b melanoma patients. A cross-sectional study.

  2019cites this paper
• Osteopontin at the Crossroads of Inflammation and Tumor Progression

  2017cites this paper
• Factors Linked to the Metastatic Spread of Malignant Cutaneous Melanoma to the Lower Extremities in a Retrospective 18F-FDG PET/CT Cohort

  2017cites this paper
• Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology

  2016cites this paper
• Correlation between theoretical anatomical patterns of lymphatic drainage and lymphoscintigraphy findings during sentinel node detection in head and neck melanomas

  2016cites this paper
• Ultrasound in the Evaluation of Cutaneous Diseases

  2016cites this paper
• The role of osteopontin expression in melanoma progression

  2015cites this paper
• ULTRASONOGRAPHY FOR LOCOREGIONAL STAGING AND FOLLOW-UP OF CUTANEOUS MELANOMA

  2015cites this paper
• Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100β.

  2015cites this paper
• Follow-up in melanoma patients

  2014cites this paper
• Melanoma M (Zero): Diagnosis and Therapy

  2013cites this paper
• Nuclear medicine in oncology 2: Breast, prostate, and cervical cancer, melanoma, and neuro-endocrine tumours

  2013cites this paper
• After Surgery: Follow-Up Guidelines of Melanoma Patients

  2013cites this paper
• Correction: Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration

  2013cites this paper
• Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration

  2013cites this paper
• Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?

  2013cites this paper
• Melanoma metastases in the abdomen and pelvis: Frequency and patterns of spread.

  2013cites this paper
• Accuracy and Reproducibility of Lymphoscintigraphy for Sentinel Node Detection in Patients with Cutaneous Melanoma

  2012cites this paper
• Vergleich der diagnostischen Genauigkeit der Ganzkörper‐MRT und Ganzkörper‐CT bei malignem Melanom im Stadium III/IV

  2011cites this paper
• Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observational cohort study.

  2011cites this paper
• Comparison of the diagnostic accuracy of whole‐body MRI and whole‐body CT in stage III/IV malignant melanoma

  2011cites this paper